{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T02:29:47Z","timestamp":1794018587673,"version":"4.8.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T00:00:00Z","timestamp":1672876800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T00:00:00Z","timestamp":1672876800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1245\/s10434-022-13010-0","type":"journal-article","created":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T09:03:56Z","timestamp":1672909436000},"page":"2634-2644","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":50,"title":["Treatment of Peritoneal Metastasis with Pressurized Intraperitoneal Aerosol Chemotherapy: Results from the Prospective PIPAC-OPC2 Study"],"prefix":"10.1245","volume":"30","author":[{"given":"Martin","family":"Graversen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Detlefsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. P.","family":"Ainsworth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. W.","family":"Fristrup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. O.","family":"Knudsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Pfeiffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. S.","family":"Tarpgaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. B.","family":"Mortensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,5]]},"reference":[{"key":"13010_CR1","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1002\/(SICI)1097-0142(20000115)88:2<358::AID-CNCR16>3.0.CO;2-O","volume":"88","author":"B Sadeghi","year":"2000","unstructured":"Sadeghi B, Arvieux C, Glehen O, et al. Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study. Cancer. 2000;88:358\u201363.","journal-title":"Cancer"},{"key":"13010_CR2","doi-asserted-by":"publisher","first-page":"6979","DOI":"10.3748\/wjg.v19.i41.6979","volume":"19","author":"F Coccolini","year":"2013","unstructured":"Coccolini F, Gheza F, Lotti M, et al. Peritoneal carcinomatosis. World J Gastroenterol. 2013;19:6979\u201394.","journal-title":"World J Gastroenterol."},{"key":"13010_CR3","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1016\/S1470-2045(16)30500-9","volume":"17","author":"J Franko","year":"2016","unstructured":"Franko J, Shi Q, Meyers JP, et al. Prognosis of patients with peritoneal metastatic colorectal cancer given systemic therapy: an analysis of individual patient data from prospective randomised trials from the Analysis and Research in Cancers of the Digestive System (ARCAD) database. Lancet Oncol. 2016;17:1709\u201319.","journal-title":"Lancet Oncol."},{"key":"13010_CR4","doi-asserted-by":"publisher","first-page":"54","DOI":"10.3390\/vaccines6030054","volume":"6","author":"A Thadi","year":"2018","unstructured":"Thadi A, Khalili M, Morano WF, et al. Early investigations and recent advances in intraperitoneal immunotherapy for peritoneal metastasis. Vaccines. 2018;6:54.","journal-title":"Vaccines"},{"key":"13010_CR5","doi-asserted-by":"publisher","first-page":"4649","DOI":"10.3390\/jcm10204649","volume":"10","author":"E Ruiz Hisp\u00e1n","year":"2021","unstructured":"Ruiz Hisp\u00e1n E, Pedregal M, Cristobal I, et al. Immunotherapy for peritoneal metastases from gastric cancer: rationale, current practice and ongoing trials. J Clin Med. 2021;10:4649.","journal-title":"J Clin Med."},{"key":"13010_CR6","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/s41572-021-00326-6","volume":"7","author":"D Cort\u00e9s-Guiral","year":"2021","unstructured":"Cort\u00e9s-Guiral D, H\u00fcbner M, Alyami M, et al. Primary and metastatic peritoneal surface malignancies. Nat Rev Dis Primers. 2021;7:91.","journal-title":"Nat Rev Dis Primers"},{"key":"13010_CR7","doi-asserted-by":"crossref","unstructured":"Eisenhauer EA, Therasse P, Bogaerts J et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 2009; 45: 228\u2013247.","DOI":"10.1016\/j.ejca.2008.10.026"},{"key":"13010_CR8","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/S2468-1253(19)30239-0","volume":"4","author":"CEL Klaver","year":"2019","unstructured":"Klaver CEL, Wisselink DD, Punt CJA, et al. Adjuvant hyperthermic intraperitoneal chemotherapy in patients with locally advanced colon cancer (COLOPEC): a multicentre, open-label, randomised trial. Lancet Gastroenterol Hepatol. 2019;4:761\u201370.","journal-title":"Lancet Gastroenterol Hepatol."},{"key":"13010_CR9","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1016\/S1470-2045(20)30322-3","volume":"21","author":"D Go\u00e9r\u00e9","year":"2020","unstructured":"Go\u00e9r\u00e9 D, Glehen O, Quenet F, et al. Second-look surgery plus hyperthermic intraperitoneal chemotherapy versus surveillance in patients at high risk of developing colorectal peritoneal metastases (PROPHYLOCHIP-PRODIGE 15): a randomised, phase 3 study. Lancet Oncol. 2020;21:1147\u201354.","journal-title":"Lancet Oncol."},{"key":"13010_CR10","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/S1470-2045(20)30599-4","volume":"22","author":"F Qu\u00e9net","year":"2021","unstructured":"Qu\u00e9net F, Elias D, Roca L, et al. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus cytoreductive surgery alone for colorectal peritoneal metastases (PRODIGE 7): a multicentre, randomised, open-label, phase 3 trial. Lancet Oncol. 2021;22:256\u201366.","journal-title":"Lancet Oncol."},{"key":"13010_CR11","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1007\/s10637-016-0369-0","volume":"34","author":"N Takahara","year":"2016","unstructured":"Takahara N, Isayama H, Nakai Y, et al. Intravenous and intraperitoneal paclitaxel with S-1 for treatment of refractory pancreatic cancer with malignant ascites. Invest New Drugs. 2016;34:636\u201342.","journal-title":"Invest New Drugs"},{"key":"13010_CR12","doi-asserted-by":"publisher","first-page":"1922","DOI":"10.1200\/JCO.2018.77.8613","volume":"36","author":"H Ishigami","year":"2018","unstructured":"Ishigami H, Fujiwara Y, Fukushima R, et al. Phase III trial comparing intraperitoneal and intravenous paclitaxel plus s-1 versus cisplatin plus s-1 in patients with gastric cancer with peritoneal metastasis: PHOENIX-GC trial. J Clin Oncol. 2018;36:1922\u20139.","journal-title":"J Clin Oncol."},{"key":"13010_CR13","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1097\/SLA.0000000000001705","volume":"265","author":"S Satoi","year":"2017","unstructured":"Satoi S, Fujii T, Yanagimoto H, et al. Multicenter phase II study of intravenous and intraperitoneal paclitaxel with s-1 for pancreatic ductal adenocarcinoma patients with peritoneal metastasis. Ann Surg. 2017;265:397\u2013401.","journal-title":"Ann Surg."},{"key":"13010_CR14","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1007\/s00464-012-2148-0","volume":"26","author":"W Solass","year":"2012","unstructured":"Solass W, Hetzel A, Nadiradze G, et al. Description of a novel approach for intraperitoneal drug delivery and the related device. Surg Endosc. 2012;26:1849\u201355.","journal-title":"Surg Endosc."},{"key":"13010_CR15","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1245\/s10434-013-3213-1","volume":"21","author":"W Solass","year":"2014","unstructured":"Solass W, Kerb R, Murdter T, et al. Intraperitoneal chemotherapy of peritoneal carcinomatosis using pressurized aerosol as an alternative to liquid solution: first evidence for efficacy. Ann Surg Oncol. 2014;21:553\u20139.","journal-title":"Ann Surg Oncol."},{"key":"13010_CR16","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1016\/j.ejso.2018.02.014","volume":"44","author":"M Nowacki","year":"2018","unstructured":"Nowacki M, Alyami M, Villeneuve L, et al. Multicenter comprehensive methodological and technical analysis of 832 pressurized intraperitoneal aerosol chemotherapy (PIPAC) interventions performed in 349 patients for peritoneal carcinomatosis treatment: an international survey study. Eur J Surg Oncol. 2018;44:991\u20136.","journal-title":"Eur J Surg Oncol."},{"key":"13010_CR17","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1002\/bjs.10521","volume":"104","author":"F Grass","year":"2017","unstructured":"Grass F, Vuagniaux A, Teixeira-Farinha H, et al. Systematic review of pressurized intraperitoneal aerosol chemotherapy for the treatment of advanced peritoneal carcinomatosis. Br J Surg. 2017;104:669\u201378.","journal-title":"Br J Surg."},{"key":"13010_CR18","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.ejso.2021.10.028","volume":"48","author":"M H\u00fcbner","year":"2022","unstructured":"H\u00fcbner M, Alyami M, Villeneuve L, et al. Consensus guidelines for pressurized intraperitoneal aerosol chemotherapy: technical aspects and treatment protocols. Eur J Surg Oncol. 2022;48:789\u201394.","journal-title":"Eur J Surg Oncol."},{"key":"13010_CR19","doi-asserted-by":"publisher","first-page":"e368","DOI":"10.1016\/S1470-2045(19)30318-3","volume":"20","author":"M Alyami","year":"2019","unstructured":"Alyami M, Hubner M, Grass F, et al. Pressurised intraperitoneal aerosol chemotherapy: rationale, evidence, and potential indications. Lancet Oncol. 2019;20:e368\u201377.","journal-title":"Lancet Oncol."},{"key":"13010_CR20","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1515\/pp-2016-0011","volume":"1","author":"W Solass","year":"2016","unstructured":"Solass W, Sempoux C, Detlefsen S, et al. Peritoneal sampling and histological assessment of therapeutic response in peritoneal metastasis: proposal of the Peritoneal Regression Grading Score (PRGS). Pleura Peritoneum. 2016;1:99\u2013107.","journal-title":"Pleura Peritoneum"},{"key":"13010_CR21","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1111\/his.13829","volume":"74","author":"W Solass","year":"2019","unstructured":"Solass W, Sempoux C, Carr NJ, et al. Reproducibility of the peritoneal regression grading score for assessment of response to therapy in peritoneal metastasis. Histopathology. 2019;74:1014\u201324.","journal-title":"Histopathology"},{"key":"13010_CR22","doi-asserted-by":"publisher","first-page":"175883591877703","DOI":"10.1177\/1758835918777036","volume":"10","author":"M Graversen","year":"2018","unstructured":"Graversen M, Detlefsen S, Bjerregaard JK, et al. Prospective, single-center implementation and response evaluation of pressurized intraperitoneal aerosol chemotherapy (PIPAC) for peritoneal metastasis. Ther Adv Med Oncol. 2018;10:1758835918777036.","journal-title":"Ther Adv Med Oncol."},{"key":"13010_CR23","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.humpath.2021.12.005","volume":"120","author":"S Detlefsen","year":"2022","unstructured":"Detlefsen S, Windedal T, Bibeau F, et al. Role of immunohistochemistry for interobserver agreement of Peritoneal Regression Grading Score in peritoneal metastasis. Hum Pathol. 2022;120:77\u201387.","journal-title":"Hum Pathol."},{"key":"13010_CR24","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.ejso.2019.08.024","volume":"46","author":"M Graversen","year":"2019","unstructured":"Graversen M, Detlefsen S, Ellebaek SB, et al. Pressurized IntraPeritoneal Aerosol Chemotherapy with one minute of electrostatic precipitation (ePIPAC) is feasible, but the histological tumor response in peritoneal metastasis is insufficient. Eur J Surg Oncol. 2019;46:155\u20139.","journal-title":"Eur J Surg Oncol."},{"key":"13010_CR25","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","volume":"240","author":"D Dindo","year":"2004","unstructured":"Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205\u201313.","journal-title":"Ann Surg."},{"key":"13010_CR26","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1093\/jnci\/85.5.365","volume":"85","author":"NK Aaronson","year":"1993","unstructured":"Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85:365\u201376.","journal-title":"J Natl Cancer Inst."},{"key":"13010_CR27","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1093\/annonc\/mdl386","volume":"18","author":"L Rubbia-Brandt","year":"2007","unstructured":"Rubbia-Brandt L, Giostra E, Brezault C, et al. Importance of histological tumor response assessment in predicting the outcome in patients with colorectal liver metastases treated with neo-adjuvant chemotherapy followed by liver surgery. Ann Oncol. 2007;18:299\u2013304.","journal-title":"Ann Oncol."},{"key":"13010_CR28","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1515\/pp-2022-0108","volume":"7","author":"M Fallah","year":"2022","unstructured":"Fallah M, Detlefsen S, Ainsworth AP, et al. Importance of biopsy site selection for peritoneal regression grading score (PRGS) in peritoneal metastasis treated with repeated pressurized intraperitoneal aerosol chemotherapy (PIPAC). Pleura Peritoneum. 2022;7:143\u20138.","journal-title":"Pleura Peritoneum"},{"key":"13010_CR29","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1111\/his.14092","volume":"77","author":"N Benzerdjeb","year":"2020","unstructured":"Benzerdjeb N, Durieux E, Tantot J, et al. Prognostic impact of combined progression index based on peritoneal grading regression score and peritoneal cytology in peritoneal metastasis. Histopathology. 2020;77:548\u201359.","journal-title":"Histopathology"},{"key":"13010_CR30","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1136\/jclinpath-2018-205683","volume":"72","author":"M Graversen","year":"2019","unstructured":"Graversen M, Fristrup C, Kristensen TK, et al. Detection of free intraperitoneal tumour cells in peritoneal lavage fluid from patients with peritoneal metastasis before and after treatment with pressurised intraperitoneal aerosol chemotherapy (PIPAC). J Clin Pathol. 2019;72:368\u201372.","journal-title":"J Clin Pathol."},{"key":"13010_CR31","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.suronc.2013.01.001","volume":"22","author":"HM Mohan","year":"2013","unstructured":"Mohan HM, O\u2019Connor DB, O\u2019Riordan JM, Winter DC. Prognostic significance of detection of microscopic peritoneal disease in colorectal cancer: a systematic review. Surg Oncol. 2013;22:e1-6.","journal-title":"Surg Oncol."},{"key":"13010_CR32","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1002\/ijc.28373","volume":"134","author":"I Thomassen","year":"2014","unstructured":"Thomassen I, van Gestel YR, van Ramshorst B, et al. Peritoneal carcinomatosis of gastric origin: a population-based study on incidence, survival and risk factors. Int J Cancer. 2014;134:622\u20138.","journal-title":"Int J Cancer"},{"key":"13010_CR33","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.ejso.2020.05.021","volume":"47","author":"M Alyami","year":"2021","unstructured":"Alyami M, Bonnot PE, Mercier F, et al. Pressurized intraperitoneal aerosol chemotherapy (PIPAC) for unresectable peritoneal metastasis from gastric cancer. Eur J Surg Oncol. 2021;47:123\u20137.","journal-title":"Eur J Surg Oncol."},{"key":"13010_CR34","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1186\/s12885-018-4363-0","volume":"18","author":"U Giger-Pabst","year":"2018","unstructured":"Giger-Pabst U, Demtr\u00f6der C, Falkenstein TA, et al. Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) for the treatment of malignant mesothelioma. BMC Cancer. 2018;18:442.","journal-title":"BMC Cancer"},{"key":"13010_CR35","doi-asserted-by":"publisher","first-page":"20200109","DOI":"10.1515\/pp-2020-0109","volume":"5","author":"SB Elleb\u00e6k","year":"2020","unstructured":"Elleb\u00e6k SB, Graversen M, Detlefsen S, et al. Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC)-directed treatment of peritoneal metastasis in end-stage colo-rectal cancer patients. Pleura Peritoneum. 2020;5:20200109.","journal-title":"Pleura Peritoneum"},{"key":"13010_CR36","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s12885-020-6572-6","volume":"20","author":"M Ploug","year":"2020","unstructured":"Ploug M, Graversen M, Pfeiffer P, Mortensen MB. Bidirectional treatment of peritoneal metastasis with Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) and systemic chemotherapy: a systematic review. BMC Cancer. 2020;20:105.","journal-title":"BMC Cancer"},{"key":"13010_CR37","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.ejso.2021.10.028","volume":"48","author":"M Hubner","year":"2022","unstructured":"Hubner M, Alyami M, Villeneuve L, et al. Consensus guidelines for pressurized intraperitoneal aerosol chemotherapy: technical aspects and treatment protocols. Eur J Surg Oncol. 2022;48:789\u201394.","journal-title":"Eur J Surg Oncol."},{"key":"13010_CR38","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1016\/j.ejso.2015.06.001","volume":"41","author":"K Odendahl","year":"2015","unstructured":"Odendahl K, Solass W, Demtroder C, et al. Quality of life of patients with end-stage peritoneal metastasis treated with Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC). Eur J Surg Oncol. 2015;41:1379\u201385.","journal-title":"Eur J Surg Oncol."},{"key":"13010_CR39","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.suronc.2020.08.012","volume":"35","author":"A Taibi","year":"2020","unstructured":"Taibi A, Geyl S, Salle H, et al. Systematic review of patient reported outcomes (PROs) and quality of life measures after pressurized intraperitoneal aerosol chemotherapy (PIPAC). Surg Oncol. 2020;35:97\u2013105.","journal-title":"Surg Oncol."},{"key":"13010_CR40","doi-asserted-by":"publisher","first-page":"20180128","DOI":"10.1515\/pp-2018-0128","volume":"3","author":"M Graversen","year":"2018","unstructured":"Graversen M, Lundell L, Fristrup C, et al. Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) as an outpatient procedure. Pleura Peritoneum. 2018;3:20180128.","journal-title":"Pleura Peritoneum"},{"key":"13010_CR41","doi-asserted-by":"publisher","first-page":"4486","DOI":"10.1007\/s00464-021-08802-6","volume":"36","author":"RJ Lurvink","year":"2022","unstructured":"Lurvink RJ, Rovers KP, Wassenaar ECE, et al. Patient-reported outcomes during repetitive oxaliplatin-based pressurized intraperitoneal aerosol chemotherapy for isolated unresectable colorectal peritoneal metastases in a multicenter, single-arm, phase 2 trial (CRC-PIPAC). Surg Endosc. 2022;36:4486\u201398.","journal-title":"Surg Endosc."},{"key":"13010_CR42","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.ygyno.2018.05.001","volume":"150","author":"CB Tempfer","year":"2018","unstructured":"Tempfer CB, Giger-Pabst U, Seebacher V, et al. A phase I, single-arm, open-label, dose escalation study of intraperitoneal cisplatin and doxorubicin in patients with recurrent ovarian cancer and peritoneal carcinomatosis. Gynecol Oncol. 2018;150:23\u201330.","journal-title":"Gynecol Oncol."},{"key":"13010_CR43","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1515\/pp-2021-0108","volume":"6","author":"MB Mortensen","year":"2021","unstructured":"Mortensen MB, Glehen O, Horvath P, et al. The ISSPP PIPAC database: design, process, access, and first interim analysis. Pleura Peritoneum. 2021;6:91\u20137.","journal-title":"Pleura Peritoneum"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-022-13010-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-022-13010-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-022-13010-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,10]],"date-time":"2023-04-10T10:05:56Z","timestamp":1681121156000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-022-13010-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,5]]},"references-count":43,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["13010"],"URL":"https:\/\/doi.org\/10.1245\/s10434-022-13010-0","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,5]]},"assertion":[{"value":"26 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have no commercial interests and\nreceived no financial or material support for this study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}